Drug Patents owned by Valeant Pharms Intl

1. Drug name - APRISO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8865688 VALEANT PHARMS INTL Compositions and methods for treatment of bowel diseases with granulated mesalamine May, 2030

(7 years from now)

Drugs and Companies using MESALAMINE ingredient

Treatment: For the maintenance of remission of ulcerative colitis

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
375MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

2. Drug name - COLAZAL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7452872 VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives Aug, 2026

(3 years from now)

US7625884 VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives Aug, 2026

(3 years from now)

US7452872

(Pediatric)

VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives Feb, 2027

(4 years from now)

US7625884

(Pediatric)

VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives Feb, 2027

(4 years from now)

Drugs and Companies using BALSALAZIDE DISODIUM ingredient

Treatment: Treatment of ulcerative colitis

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
750MG CAPSULE;ORAL Prescription

3. Drug name - GIAZO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9192616 VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives Aug, 2026

(3 years from now)

US7452872 VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives Aug, 2026

(3 years from now)

US7625884 VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives Aug, 2026

(3 years from now)

US8497256 VALEANT PHARMS INTL Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males Jun, 2031

(8 years from now)

Drugs and Companies using BALSALAZIDE DISODIUM ingredient

Treatment: Treatment of mildly to moderately active ulcerative colitis in male patients

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
1.1GM TABLET;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.